Stockscreener 앱 받기
9.69
7.27%
-0.76
시간 외 거래:
9.69
전일 마감가:
$10.45
열려 있는:
$10.06
하루 거래량:
14,907
Relative Volume:
0.02
시가총액:
$8.93M
수익:
$29,000
순이익/손실:
$1.43M
주가수익비율:
-0.3597
EPS:
-26.9407
순현금흐름:
$-3.58M
1주 성능:
-6.83%
1개월 성능:
+3.42%
6개월 성능:
-26.59%
1년 성능:
-56.92%
1일 변동 폭
$9.56
$10.22
1주일 범위
$9.56
$10.45
52주 변동 폭
$6.00
$28.44
Pavmed Inc Stock (PAVM) Company Profile
명칭
Pavmed Inc
전화
(212) 949-4319
주소
360 MADISON AVENUE, NEW YORK, NY
Compare PAVM vs ABT, SYK, MDT, BSX, EW
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PAVM
Pavmed Inc
|
9.69 | 9.63M | 29,000 | 1.43M | -3.58M | -26.94 |
|
ABT
Abbott Laboratories
|
107.19 | 188.52B | 44.33B | 6.50B | 7.40B | 3.717 |
|
SYK
Stryker Corp
|
339.76 | 132.34B | 25.12B | 3.25B | 4.28B | 8.3984 |
|
MDT
Medtronic Plc
|
86.87 | 111.97B | 35.48B | 4.64B | 5.41B | 3.582 |
|
BSX
Boston Scientific Corp
|
69.89 | 105.77B | 20.08B | 2.89B | 3.66B | 1.9391 |
|
EW
Edwards Lifesciences Corp
|
82.46 | 47.98B | 6.07B | 1.06B | 1.34B | 1.8063 |
Pavmed Inc Stock (PAVM) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2021-03-30 | 개시 | Cantor Fitzgerald | Overweight |
| 2020-11-05 | 개시 | Ascendiant Capital Markets | Buy |
| 2018-06-28 | 개시 | Maxim Group | Buy |
Pavmed Inc 주식(PAVM)의 최신 뉴스
Resistance Check: Is PAVmed Inc stock a value trap2026 Key Lessons & Precise Buy Zone Tips - baoquankhu1.vn
Aug Opening: Is PAVmed Inc a stock for growth or value investorsDollar Strength & AI Driven Price Predictions - baoquankhu1.vn
PAVM.O Technical Analysis & Stock Price Forecast - Intellectia AI
Short Covering: Whats next for PAVmed Inc stockEarnings Overview Summary & Free Real-Time Volume Trigger Notifications - baoquankhu1.vn
PAVmed to Hold Q4 and Full Year 2025 Business Update Call on March 30, 2026 - National Today
Price Action: Does PAVmed Inc have pricing power2026 Decliners & Entry Point Confirmation Alerts - baoquankhu1.vn
PAVmed executives to outline 2025 strategy, Q4 results on March 30 call - Stock Titan
LUCD SEC FilingsLucid Diagnostics Inc. 10-K, 10-Q, 8-K Forms - Stock Titan
Lucid Diagnostics to Hold Fourth Quarter and Full Year 2025 Business Update Conference Call and Webcast on March 26, 2026 - Sahm
Analyst Upgrade: Is PAVmed Inc stock a value trap2026 Intraday Action & Safe Entry Trade Reports - baoquankhu1.vn
Stock Recap: Can PAVmed Inc expand into new markets2026 Earnings Surprises & Weekly Watchlist for Consistent Profits - baoquankhu1.vn
PAVM.O Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Should I Buy - Intellectia AI
Panic Selling: Can PAVmed Inc maintain its current growth rateQuarterly Market Summary & Weekly Consistent Profit Watchlists - baoquankhu1.vn
Earnings Risk: Whats next for PAVmed Inc stockJuly 2025 Catalysts & Safe Capital Preservation Plans - baoquankhu1.vn
PAVM Stock News Today | Earnings, Events & Price Alerts - Intellectia AI
PAVM Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
PAVmed (NASDAQ: PAVM) seeks approval for major share and equity plan changes - Stock Titan
Levels Update: Is PAVmed Inc stock a value trapInflation Watch & Step-by-Step Trade Execution Guides - baoquankhu1.vn
Volatility Watch: Is NVR Inc stock trending bullish2025 Price Momentum & Weekly High Momentum Picks - baoquankhu1.vn
Lucid Diagnostics Provides Business Update and Reports Third Quarter 2025 Financial Results - Intellectia AI
Earnings Recap: What is PAVmed Incs market position2025 Investor Takeaways & Community Shared Stock Ideas - baoquankhu1.vn
Ayrton Capital LLC Reduces Stake in Traws Pharma Inc - GuruFocus
Is PAVmed Inc. stock a value trapJuly 2025 Fed Impact & Verified Technical Trade Signals - mfd.ru
Is PAVmed Inc. stock a top performer YTDJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - mfd.ru
Can PAVmed Inc. sustain its profitabilityTrade Risk Assessment & Stepwise Swing Trade Plans - mfd.ru
Signal Recap: Will PAVmed Inc stock hit new highs in YEARInsider Buying & Real-Time Volume Triggers - baoquankhu1.vn
Aug Sectors: Is PAVmed Inc a potential multi baggerWeekly Gains Report & Daily Risk Controlled Trade Plans - baoquankhu1.vn
PAVmed Restructures Capital With New Preferred Financing - The Globe and Mail
Lucid Diagnostics Awarded U.S. Department of Veterans Affairs Contract for EsoGuard® - Eastern Progress
PAVmed raises $45 million, restructures capital to eliminate convertible debt - Investing.com
PAVmed raises $45 million, restructures capital to eliminate convertible debt By Investing.com - Investing.com India
PAVmed Signs Multiple Financing Agreements - TradingView
PAVmed Closes Preferred Stock and Senior Secured Note Financings, Eliminating All Previously Outstanding Convertible Securities - PR Newswire
PAVmed Inc. announced that it expects to receive $30 million in funding - marketscreener.com
12 Health Care Stocks Moving In Monday's Intraday Session - Benzinga
Lucid Diagnostics inks deal with VA to use esophageal cancer screen - Crain's New York Business
Technical Analysis: Is PAVmed Inc a stock for growth or value investorsMarket Performance Recap & High Return Trade Opportunity Guides - baoquankhu1.vn
What makes PAVmed Inc. stock attractive todayM&A Rumor & Consistent Profit Trading Strategies - mfd.ru
Lucid Diagnostics to Hold a Business Update Conference Call and Webcast on May 14, 2025 - Quantisnow
Lucid Diagnostics: Green Flags, But Dilution And Friction Keep Me Neutral (LUCD) - Seeking Alpha
PAVmed subsidiary Lucid Diagnostics spikes on Veterans Affairs contract - MSN
PAVmed Regains Compliance with Nasdaq Minimum Bid Price - The Globe and Mail
12 Health Care Stocks Moving In Friday's Intraday Session - Benzinga
Individual investors among Lucid Diagnostics Inc.'s (NASDAQ:LUCD) largest stockholders and were hit after last week's 14% price drop - simplywall.st
What's Going On With PAVmed Shares Thursday? - Benzinga
Should you chase the rally in PAVmed stock after it quadrupled on Wednesday? - MEXC
PAVmed stock dips premarket after VA contract drives near-double rally in PAVM shares - TechStock²
Lucid Diagnostics secures VA contract for esophageal cancer test By Investing.com - Investing.com Nigeria
Crypto: PAVM at Critical Level: Why This Week Matters - InteractiveCrypto
PAVmed Inc. Stock (PAVM) Opinions on VA Contract Win - Quiver Quantitative
Pavmed Inc (PAVM) 재무 분석
매출
순이익
현금흐름
주당 순 이익
0.85%
1.86%
자본화:
|
볼륨(24시간):